EXG110

· Guangzhou Jiayin Biotech Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EXG110, covering 2025-02-11 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease [NA]